These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 16107832)

  • 21. Regulation of hepatitis C virus replication by microRNAs.
    Pietschmann T
    J Hepatol; 2009 Mar; 50(3):441-4. PubMed ID: 19155089
    [No Abstract]   [Full Text] [Related]  

  • 22. High-throughput screening of HCV RNA replication inhibitors by means of a reporter replicon system.
    Hao W; Duggal R
    Methods Mol Biol; 2009; 510():243-50. PubMed ID: 19009266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclophilin B escorts the hepatitis C virus RNA polymerase: a viral achilles heel?
    Heitman J; Cullen BR
    Mol Cell; 2005 Jul; 19(2):145-6. PubMed ID: 16039584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis A protein VP1-2A reduced cell viability in Huh-7 cells with hepatitis C virus subgenomic RNA replication.
    Kanda T; Yokosuka O; Imazeki F; Fujiwara K; Saisho H
    J Gastroenterol Hepatol; 2006 Mar; 21(3):625-6. PubMed ID: 16638117
    [No Abstract]   [Full Text] [Related]  

  • 25. New efficient replication system with hepatitis C virus genome derived from a patient with acute hepatitis C.
    Mori K; Abe K; Dansako H; Ariumi Y; Ikeda M; Kato N
    Biochem Biophys Res Commun; 2008 Jun; 371(1):104-9. PubMed ID: 18406345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication.
    Ariumi Y; Kuroki M; Abe K; Dansako H; Ikeda M; Wakita T; Kato N
    J Virol; 2007 Dec; 81(24):13922-6. PubMed ID: 17855521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3-Amino-2(5H)furanones as inhibitors of subgenomic hepatitis C virus RNA replication.
    Iannazzo D; Piperno A; Romeo G; Romeo R; Chiacchio U; Rescifina A; Balestrieri E; Macchi B; Mastino A; Cortese R
    Bioorg Med Chem; 2008 Nov; 16(21):9610-5. PubMed ID: 18835180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reverse transcription PCR-based sequence analysis of hepatitis C virus replicon RNA.
    Tellinghuisen TL; Lindenbach BD
    Methods Mol Biol; 2009; 510():165-75. PubMed ID: 19009260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell culture and infection system for hepatitis C virus.
    Kato T; Date T; Murayama A; Morikawa K; Akazawa D; Wakita T
    Nat Protoc; 2006; 1(5):2334-9. PubMed ID: 17406476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new living cell-based assay system for monitoring genome-length hepatitis C virus RNA replication.
    Dansako H; Ikeda M; Abe K; Mori K; Takemoto K; Ariumi Y; Kato N
    Virus Res; 2008 Oct; 137(1):72-9. PubMed ID: 18602954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular and molecular biology of HCV infection and hepatitis.
    Tang H; Grisé H
    Clin Sci (Lond); 2009 Jun; 117(2):49-65. PubMed ID: 19515018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of the hepatitis C virus replication complex.
    Brass V; Gosert R; Moradpour D
    Methods Mol Biol; 2009; 510():195-209. PubMed ID: 19009263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus comes full circle: production of recombinant infectious virus in tissue culture.
    Berke JM; Moradpour D
    Hepatology; 2005 Dec; 42(6):1264-9. PubMed ID: 16317703
    [No Abstract]   [Full Text] [Related]  

  • 34. Paramyxovirus Sendai virus C proteins are essential for maintenance of negative-sense RNA genome in virus particles.
    Irie T; Nagata N; Yoshida T; Sakaguchi T
    Virology; 2008 May; 374(2):495-505. PubMed ID: 18252261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus.
    Jones CT; Murray CL; Eastman DK; Tassello J; Rice CM
    J Virol; 2007 Aug; 81(16):8374-83. PubMed ID: 17537845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production of infectious hepatitis C virus in tissue culture: a breakthrough for basic and applied research.
    Zeisel MB; Baumert TF
    J Hepatol; 2006 Feb; 44(2):436-9. PubMed ID: 16360233
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hepatitis C virus--structure, replication and therapeutical opportunities and the phenomenon of resistance].
    Kowala-Piaskowska A
    Postepy Biochem; 2006; 52(4):399-407. PubMed ID: 17536509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent contributions of in vitro models to our understanding of hepatitis C virus life cycle.
    Régeard M; Lepère C; Trotard M; Gripon P; Le Seyec J
    FEBS J; 2007 Sep; 274(18):4705-18. PubMed ID: 17824957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Host factors involved in regulation of replication and pathogenesis of hepatitis C virus ].
    Moriisi K; Mori Y; Taguwa S; Matsuura Y
    Tanpakushitsu Kakusan Koso; 2009 Jun; 54(8 Suppl):940-6. PubMed ID: 21089521
    [No Abstract]   [Full Text] [Related]  

  • 40. PKR protein kinase is activated by hepatitis C virus and inhibits viral replication through translational control.
    Kang JI; Kwon SN; Park SH; Kim YK; Choi SY; Kim JP; Ahn BY
    Virus Res; 2009 Jun; 142(1-2):51-6. PubMed ID: 19189853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.